Discovery of survival predictor and early monitoring biomarkers for EGFR tyrosine kinase inhibitor therapy in lung adenocarcinoma by integrative omics analysis

Ting-Feng Hsiao; Chih-Liang Wang; Yi-Cheng Wu; Hsiang-Pu Feng; Yen-Chuan Chiu; Hao-Yu Lin; Ko-Jiunn Liu; Gee-Chen Chang; Kun-Yi Chien; Jau-Song Yu; Chia-Jung Yu

doi:10.1096/fasebj.2020.34.s1.08868

Discovery of survival predictor and early monitoring biomarkers for EGFR tyrosine kinase inhibitor therapy in lung adenocarcinoma by integrative omics analysis

Ting-Feng Hsiao, Chih-Liang Wang, Yi-Cheng Wu, Hsiang-Pu Feng, Yen-Chuan Chiu, Hao-Yu Lin, Ko-Jiunn Liu, Gee-Chen Chang, Kun-Yi Chien, Jau-Song Yu, Chia-Jung Yu

Research output: Contribution to journal › Journal Article › peer-review

Original language	American English
Journal	FASEB Journal
Volume	34
DOIs	https://doi.org/10.1096/fasebj.2020.34.s1.08868
State	Published - 2020

Access to Document

10.1096/fasebj.2020.34.s1.08868

Cite this

Hsiao, T.-F., Wang, C.-L., Wu, Y.-C., Feng, H.-P., Chiu, Y.-C., Lin, H.-Y., Liu, K.-J., Chang, G.-C., Chien, K.-Y., Yu, J.-S., & Yu, C.-J. (2020). Discovery of survival predictor and early monitoring biomarkers for EGFR tyrosine kinase inhibitor therapy in lung adenocarcinoma by integrative omics analysis. FASEB Journal, 34. https://doi.org/10.1096/fasebj.2020.34.s1.08868

@article{a3b5d19ff7a141e5812048b6d12b8dc7,

title = "Discovery of survival predictor and early monitoring biomarkers for EGFR tyrosine kinase inhibitor therapy in lung adenocarcinoma by integrative omics analysis",

author = "Ting-Feng Hsiao and Chih-Liang Wang and Yi-Cheng Wu and Hsiang-Pu Feng and Yen-Chuan Chiu and Hao-Yu Lin and Ko-Jiunn Liu and Gee-Chen Chang and Kun-Yi Chien and Jau-Song Yu and Chia-Jung Yu",

year = "2020",

doi = "10.1096/fasebj.2020.34.s1.08868",

language = "American English",

volume = "34",

journal = "FASEB Journal",

issn = "0892-6638",

publisher = "John Wiley & Sons Inc.",

}

TY - JOUR

T1 - Discovery of survival predictor and early monitoring biomarkers for EGFR tyrosine kinase inhibitor therapy in lung adenocarcinoma by integrative omics analysis

AU - Hsiao, Ting-Feng

AU - Wang, Chih-Liang

AU - Wu, Yi-Cheng

AU - Feng, Hsiang-Pu

AU - Chiu, Yen-Chuan

AU - Lin, Hao-Yu

AU - Liu, Ko-Jiunn

AU - Chang, Gee-Chen

AU - Chien, Kun-Yi

AU - Yu, Jau-Song

AU - Yu, Chia-Jung

PY - 2020

Y1 - 2020

U2 - 10.1096/fasebj.2020.34.s1.08868

DO - 10.1096/fasebj.2020.34.s1.08868

M3 - Journal Article

SN - 0892-6638

VL - 34

JO - FASEB Journal

JF - FASEB Journal

ER -